Inactive Instrument
Quotes Celsion Corporation Nasdaq
Stocks
US15117N4043
Biotechnology & Medical Research
|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| 09-24 | IMUNON, Inc. Presents Update On IMNN-001 Development Program For Women With Newly Diagnosed Advanced Ovarian Cancer | CI |
| 09-23 | Imunon, Inc. - Shareholder/Analyst Call |
Stock exchange
Basic data
Market Cap (USD)
6,284,771
Net sales (USD)
0
Free-Float
94.27%
Free-Float capitalization (USD)
5,924,391
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | 0.00% | - | - | 6.28M | |
| +4.16% | +4.16% | +49.37% | +94.17% | 74.69B | |
| +0.46% | -1.16% | +23.36% | +79.34% | 58.81B | |
| +0.17% | -1.16% | +3.59% | +34.55% | 48.45B | |
| +0.50% | -2.14% | +331.33% | +688.65% | 42.84B | |
| -0.72% | -3.99% | +28.50% | +29.35% | 42.79B | |
| +0.34% | -0.52% | +6.56% | +110.67% | 41.25B | |
| -0.11% | +1.96% | +9.19% | +52.66% | 31.13B | |
| -2.07% | +1.16% | +35.00% | +26.28% | 30.28B | |
| -0.50% | -3.10% | -10.19% | -12.86% | 24.05B | |
| Average | +0.06% | -0.25% | +52.97% | +122.53% | 39.43B | |
| Weighted average by Cap. | +0.53% | -0.54% | +55.85% | +128.90% |
Historical Quotes: Celsion Corporation
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Price Extremes
- Stock Market
- Stocks
- IMNN Stock
- Stock
- Quotes Celsion Corporation
Select your edition
All financial news and data tailored to specific country editions
